These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26379960)

  • 1. Relationship between the total length of the stents and patients' quality of life after percutaneous coronary intervention.
    Liu W; Yang X; Dong P; Li Z
    Int J Clin Exp Med; 2015; 8(7):11435-41. PubMed ID: 26379960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
    Cohen DJ; Van Hout B; Serruys PW; Mohr FW; Macaya C; den Heijer P; Vrakking MM; Wang K; Mahoney EM; Audi S; Leadley K; Dawkins KD; Kappetein AP;
    N Engl J Med; 2011 Mar; 364(11):1016-26. PubMed ID: 21410370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of smoking on health-related quality of Life after percutaneous coronary intervention treated with drug-eluting stents: a longitudinal observational study.
    Xue C; Bian L; Xie YS; Yin ZF; Xu ZJ; Chen QZ; Zhang HL; Wang CQ
    Health Qual Life Outcomes; 2017 Jan; 15(1):1. PubMed ID: 28069015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Covariance analysis on the change of quality of life affected by percutaneous coronary intervention for patients with coronary heart disease].
    Lu YH; Yan JH; Sun LX; Li Q; Wang YJ; Zhuang X; Zhang ZF; Fan ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jan; 31(1):87-91. PubMed ID: 20302707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
    Abdallah MS; Wang K; Magnuson EA; Osnabrugge RL; Kappetein AP; Morice MC; Mohr FA; Serruys PW; Cohen DJ;
    J Am Coll Cardiol; 2017 Apr; 69(16):2039-2050. PubMed ID: 28427580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
    Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple vessel stenting for triple vessel coronary disease.
    Villegas B; Morice MC; Hernandez S; Choussat R; Dumas P; Lefevre T; Louvard Y; Loubeyre C; Fajadet J; Marco J
    J Invasive Cardiol; 2002 Jan; 14(1):1-5. PubMed ID: 11773686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass.
    Katz MR; Van Praet F; de Canniere D; Murphy D; Siwek L; Seshadri-Kreaden U; Friedrich G; Bonatti J
    Circulation; 2006 Jul; 114(1 Suppl):I473-6. PubMed ID: 16820621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of percutaneous coronary intervention and 
medical therapy on quality of life and cognitive function in patients with coronary heart disease].
    Cao F; Zhang B; Li X; Duan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):544-551. PubMed ID: 29886471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us?
    Kulik A
    Curr Opin Cardiol; 2017 Nov; 32(6):707-714. PubMed ID: 28834794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.
    Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial.
    Zhang Z; Mahoney EM; Stables RH; Booth J; Nugara F; Spertus JA; Weintraub WS
    Circulation; 2003 Oct; 108(14):1694-700. PubMed ID: 12975252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative percutaneous coronary intervention in patients undergoing open thoracoabdominal and descending thoracic aneurysm repair.
    Girardi LN; Rabotnikov Y; Avgerinos DV
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):163-8. PubMed ID: 24176270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease.
    Kornowski R; Vaknin-Assa H; Assali A; Fuchs S
    Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database.
    Kugelmass AD; Cohen DJ; Houser F; Mack M; Simon AW; Battaglia SL; Tarkington LG; Becker ER; Culler SD
    J Invasive Cardiol; 2003 Oct; 15(10):568-74. PubMed ID: 14519889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.